medigraphic.com
ISSN 1561-3194 (Electronic)

2022, Number 3

<< Back Next >>

Rev Ciencias Médicas 2022; 26 (3)

Chronic diseases and smoking in SARS-CoV-2 infection in Pinar del Rio

Valdés-Lanza L, Orraca-Castillo O, Lardoeyt-Ferrer R, Orraca-Castillo M, Martínez-Carmona Y, Miló-Valdés CA

Language: Spanish
References: 24
Page: 1-11
PDF size: 584.50 Kb.


ABSTRACT

Introduction: the world deals with a new pandemic because of SARS-CoV-2 outbreak initiated in Wuhan, China in December 2019. Host genetic differences and risk factors such as: personal history, lifestyles and environmental factors may contribute to the marked inter-individual clinical variability in COVID-19.
Objective: to identify personal pathological history (chronic diseases and smoking) associated with SARS-CoV-2 infection.
Methods: analytical, observational study of cases and controls in Pinar del Rio in the period from March 2020 to March 2021. Personal history of chronic diseases and smoking as an environmental factor were explored.
Results: personal pathological history of allergies and asthma constituted risk factors to develop symptoms. History of active smoking is presented as a risk factor for infection.
Conclusions: the contribution of personal pathological history (allergy and asthma) and environmental (active smoking) to SARS-CoV-2 infection and to the development of symptoms in COVID-19 patients in Pinar del Rio is confirmed.


REFERENCES

  1. Cajamarca Baron J, Guavita Navarro D, Buitrago Bohorquez J, Gallego Cardona L, Navas A, Cubides H, et al. SARS-CoV-2 (COVID-19) en pacientes con algún grado de inmunosupresión. Reumatol Clínica [Internet]. 2021 [citado: 21/10/2020]; 17(7): 408-419. Disponible en: Disponible en: https://doi.org/10.1016/j.reuma.2020.08.004 1.

  2. Min Z, Jun C, Fu F, Shu Q, Hu Y, Chun C, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr [Internet]. 2020 [citado: 15/03/2020]; 16: 240-246. Disponible en: Disponible en: https://doi.org/10.1007/s12519-020-00345-5 2.

  3. Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB. The role of host genetics in the immune response to SARS- CoV-2 and COVID-19 susceptibility and severity. Immunol Rev [Internet]. 2020 [citado: 21/10/2020]; 296(1): 205-19. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404857/ 3.

  4. Hanif M, Haider MA, Xi Q, Ali MJ, Ahmed MU. A Review of the Risk Factors Associated With Poor Outcomes in Patients With Coronavirus Disease 2019. Cureus [Internet]. 2020 [citado: 21/10/2020]; 12(9): e10350. Disponible en: Disponible en: https://doi.org/10.7759/cureus.10350%0A 4.

  5. Radzikowska U, Traidl-hoffmann C, Akdis C, Sokolowska M, Au N, Ca A. Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy [Internet]. 2020 [citado: 21/10/2020]; 75(11): 2829-45. Disponible en: Disponible en: https://doi.org/10.1111/all.14429 5.

  6. Rosas Arango SM, Ángel Caraza A, Del Ángel Caraza J, Soriano Vargas E. Infección por COVID-19 , una mirada a los factores ambientales relacionados con la pandemia. NOVA [Internet]. 2020 [citado: 21/10/2020]; 18(35): 101-5. Disponible en: Disponible en: https://doi.org/10.22490/24629448.4193 6.

  7. Piñera Castro HJ, Ruiz Gonzalez LA. Implicaciones del tabaquismo en el contexto de la COVID-19. Rev cub med Mil [Internet]. 2022 [citado: 10/01/2022]; 51(1): e02201457. Disponible en: Disponible en: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/1457/1014 7.

  8. Wang, Dawei, Bo Hu, Chang Hu FZ, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA [Internet]. 2020 [citado: 21/10/2020]; 323(11): 1061-1069. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042881/ 8.

  9. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the Novel Wuhan Coronavirus (COVID-19) infection: a systematic review and meta-analysis. J Inter Infect Dis [Internet]. 2020 [citado: 21/10/2020]; 94(10): 91-5. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S1201971220301363?via%3Dihub 9.

  10. Costa de Lucena T, Fernandes da Silva Santos A, de Albuquerque Borborema ME, de Azevedo Silva J. Mechanism of in fl ammatory response in associated comorbidities in COVID-19. Diabetes Metab Syndr Clin Res Rev [Internet]. 2020 [citado: 21/10/2020]; 14(4): 597-600. Disponible en: Disponible en: https://doi.org/10.1016/j.dsx.2020.05.025 10.

  11. Pérez Caballero MD, León Alvárez JL, Dueñas Herrera A, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hipertención. Rev Cuba med [Internet]. 2017 [citado: 21/10/2020]; 56(4): 242-231. Disponible en: http://scielo.sld.cu.php

  12. Zhang JJ, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy [Internet]. 2020 [citado: 21/10/2020]; 75(7): 1730-41. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32077115/ 12.

  13. Ravichandran B, Grimm D, Infanger M, Wehland M, Kopp S. SARS-CoV-2 and hypertension. Physiological Reports [Internet]. 2021 [citado: 06/10/2021]; 9(11): e14800. Disponible en: Disponible en: https://doi.org/10.14814/phy2.14800 13.

  14. Li J, Liu HH, Yin XD, Li C. COVID-19 illness and autoimmune diseases: recent insights.pdf. Inflamm Res Off J Eur Histamine Res Soc [Internet]. 2021 [citado: 06/10/2021]; 70(4): 407-28. Disponible en: Disponible en: https://doi.org/10.1007/s00011-021-01446-1 14.

  15. Zen M, Fuzzi E, Astorri D, et al. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: a cross-sectional study on 916 patients. J Autoimmun [Internet]. 2020 [citado: 06/10/2021]; 112: 102502. Disponible en: Disponible en: https://doi.org/10.1016/j.jaut.2020.102502 15.

  16. Michael RE, Stronf K, Cameron A, Walton RP, Jackson DJ, Johoston SL, et al. Viral Infections in allergy and immunology: How allergic inflamatio influences viral infections and illness. J Allergy Clin Immunol [Internet]. 2017 [citado: 06/10/2021]; 140(4): 909-20. Disponible en: Disponible en: https://doi.org/10.1016/j.jaci.2017.07.025 16.

  17. L AF. Para la salud, debates científicos oportunos [Internet]. Granma [Internet] 2017 [citado: 06/10/2021]; (2): 2-3. Disponible en: Disponible en: https://www.granma.cu/todo-salud/2017-10-06/para-la-salud-dos-debates-cientificos-oportunos-06-10-2017-00-10-23 17.

  18. Orraca O, Navarro E, Quintero W, Blanco TM, Rodríguez LR. Frecuencia de infecciones respiratorias agudas en niños y adolescentes con asma de la provincia de Pinar del Río. MEDISAN [Internet]. 2018 [citado: 06/10/2021]; 22(1): 33-9. Disponible en: Disponible en: https://scielo.sld.cu/scielo.php?script=sci-arttext&pid=S1029-30192018000100005&Ing=es 18.

  19. Papadopoulos NG, Xepapadaki P. Papel de las infecciones virales en el asma. Salud(i)Ciencia [Internet]. 2017 [citado: 06/10/2021]; 22(6): 545-51. Disponible en: Disponible en: https://www.dx.doi.org/10.21840/siic/75594 19.

  20. Licari A, Votto M, Brambilla I, et al. Allergy and asthma in children and adolescent during the COVID-19 ioutbreak: What we know and how we could prevent allergy and asthma flares. Allergy [Internet]. 2020 [citado: 06/10/2021]; 75(9): 2402-5. Disponible en: Disponible en: https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/es/covidwho-276469 20.

  21. Hosoki K, Chakraborty A, Sur S. Molecular mechanisms and epidemiology of COVID-19 from an allergist ’ s perspective. J ALLERGY CLIN IMMUNOL [Internet]. 2020 [citado: 06/10/2021]; 146(2): 285-99. Disponible en: Disponible en: https://doi.org/10.1016/j.jaci.2020.05.033 21.

  22. OMS. Declaración de la OMS: consumo de tabaco y COVID-19 [Internet]. 2020 [citado: 06/10/2021]. Disponible en: Disponible en: http://www.who.int/es/news/item/11-05-2020-who-statement-tobacco-use-and-covid-19 22.

  23. Garufi Giovanna, Carbognin L, Orlandi A, Tortora G BE. Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)- related pneumonia: The unsolved paradox behind the evidence. Eur J Intern Med [Internet]. 2020 [citado: 10/01/2022]; 77(4): 121-2. Disponible en: Disponible en: https://doi.org/10.1016/j.ejim.2020.04.042 23.

  24. Fernández Rúa JM. Nueva amenaza del tabaco en pacientes con COVID-19. Biotech Magazine [Internet]. 2021 [citado: 10/01/2022]; 3: 1-3. Disponible en: Disponible en: https://biotechmagazineandnews.com/nueva-amenaza-del-tabaco-en-pacientes-de-covid-19/24.




2020     |     www.medigraphic.com